Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PRESTIGE CONSUMER HEALTHCARE INC.

(PBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization1 1 5491 8442 1982 989--
Enterprise Value (EV)1 1 5491 8442 1982 9892 9892 989
P/E ratio -43,3x13,2x13,6x15,4x14,0x13,1x
Yield ------
Capitalization / Revenue 1,59x1,91x2,33x2,82x2,73x2,68x
EV / Revenue 1,59x1,91x2,33x2,82x2,73x2,68x
EV / EBITDA 4,67x5,62x6,68x8,29x7,98x7,63x
Price to Book 1,41x1,59x1,62x1,94x1,71x-
Nbr of stocks (in thousands) 51 79850 26649 86550 104--
Reference price (USD) 29,936,744,159,759,759,7
Announcement Date 05/09/201905/07/202005/06/2021---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales1 9769639431 0601 0961 114
EBITDA1 331328329361374392
Operating profit (EBIT)1 300299299326342350
Operating Margin 30,7%31,1%31,7%30,8%31,2%31,4%
Pre-Tax Profit (EBT)1 -38,1191204260287304
Net income1 -35,8142165197217231
Net margin -3,67%14,8%17,5%18,6%19,8%20,7%
EPS2 -0,692,783,253,884,274,55
Dividend per Share ------
Announcement Date 05/09/201905/07/202005/06/2021---
1 USD in Million
2 USD
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales1 238269276260254280
EBITDA1 79,299,092,783,584,696,4
Operating profit (EBIT)1 71,791,384,875,176,088,3
Operating Margin 30,1%33,9%30,7%28,9%29,9%31,5%
Pre-Tax Profit (EBT)1 40,476,459,659,260,473,7
Net income1 35,557,845,344,845,756,0
Net margin 14,9%21,5%16,4%17,2%18,0%20,0%
EPS2 0,701,140,890,880,901,10
Dividend per Share ------
Announcement Date 05/06/202108/05/202111/04/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 179203213222252277
ROE (Net Profit / Equities) 12,8%13,4%13,0%13,4%12,5%12,3%
Shareholders' equity1 -2791 0661 2701 4701 7371 878
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 21,223,127,230,734,9-
Cash Flow per Share ------
Capex1 10,514,622,216,216,217,8
Capex / Sales 1,07%1,51%2,36%1,53%1,47%1,60%
Announcement Date 05/09/201905/07/202005/06/2021---
1 USD in Million
2 USD
Previous periodNext period
Key data
Capitalization (USD) 2 988 713 203
Net sales (USD) 943 365 000
Number of employees 505
Sales / Employee (USD) 1 868 050
Free-Float 91,6%
Free-Float capitalization (USD) 2 739 002 232
Avg. Exchange 20 sessions (USD) 14 516 582
Average Daily Capital Traded 0,49%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA